EDA and congenital diaphragmatic hernia: ED1 immunohistochemistry revealed significantly reduced numbers of pulmonary monocytes/macrophages in sections of rosiglitazone-treated animals compared to placebo-treated CDH animals (19.8±4 vs. 26.4±-5.0, p = 0.006; Fig 5).